Literature DB >> 8254263

Exploratory data analysis of hyperlipidemia on the Macintosh: software tools for analysis of biochemical, clinical, and genetic variables in 1677 consecutive lipid clinic patients.

V Bhushan1, M J Malloy, M M Engler, M B Engler, D Drown, J P Kane.   

Abstract

Exploratory data analysis (EDA) software facilitates unstructured, iterative open exploration of complex datasets with the aid of multiple linked graphical displays. We are investigating relationships between plasma lipoproteins and coronary artery disease by retrospective analysis of 1677 consecutive UCSF Lipid Clinic patients. Our preliminary experience is with Data Deck 3.0 although several additional software programs (JMP 2.0, Systat 5.1, Minitab 8.0, StatView 4.0) are mentioned. Lipid diagnosis (751 women and 925 men) was 22% primary hypercholesterolemia, 19% combined hyperlipidemia, 3% dysbetalipoproteinemia, 15% endogenous lipemia, 4% mixed lipemia, 5% elevated Lp(a) and 32% with no major lipid abnormality. We found the Macintosh platform (68030) to be flexible and powerful for analysis of moderate size (less than 1 Mb) clinical datasets. High resolution color monitors (1024 x 768 pixels), fast hard disks (< 18 msec) and moderate amounts of system memory (8 + Mb) facilitate exploratory analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254263     DOI: 10.1007/bf00996944

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  9 in total

Review 1.  Asymptomatic hypercholesterolemia: a clinical policy review. The Toronto Working Group on Cholesterol Policy.

Authors: 
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

2.  Cluster analysis of an insulin-dependent diabetic cohort towards the definition of clinical subtypes.

Authors:  A Ciampi; A Schiffrin; J Thiffault; H Quintal; G Weitzner; P Poussier; D Lalla
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  Temporal representation of clinical algorithms using expert-system and database tools.

Authors:  D W Rucker; D J Maron; E H Shortliffe
Journal:  Comput Biomed Res       Date:  1990-06

4.  Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.

Authors:  P De Knijff; A F Stalenhoef; M J Mol; J A Gevers Leuven; J Smit; D W Erkelens; J Schouten; R R Frants; L M Havekes
Journal:  Atherosclerosis       Date:  1990-07       Impact factor: 5.162

5.  Interpreting multiple logistic regression coefficients in prospective observational studies.

Authors:  R D Abbott; R J Carroll
Journal:  Am J Epidemiol       Date:  1984-05       Impact factor: 4.897

6.  Classification of hyperlipoproteinaemias by computer interpretation.

Authors:  J F Loughlin; F Y Leung; A R Henderson
Journal:  Ann Clin Biochem       Date:  1984-07       Impact factor: 2.057

7.  Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.

Authors:  R J Havel; L Kotite; J P Kane; P Tun; T Bersot
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Comparison of plasma lipids, lipoproteins and dyslipoproteinemia in Israel and the United States. The Lipid Research Clinics Program Prevalence Study.

Authors:  S Eisenberg; G Heiss; Y Friedlander; B Rifkind; P Segal; O D Williams; Y Stein
Journal:  Atherosclerosis       Date:  1986-01       Impact factor: 5.162

9.  Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.

Authors:  H H Hobbs; E Leitersdorf; C C Leffert; D R Cryer; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.